Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: A community-based study over two decades

European Heart Journal

Volumn 27, Issue 8, 2006, Pages 936-941

  Miyasaka, Yoko ^a   Barnes, Marion E ^a   Gersh, Bernard J ^a   Cha, Stephen S ^a   Bailey, Kent R ^a   Abhayaratna, Walter ^a   Seward, James B ^a   Iwasaka, Toshiji ^b   Tsang, Teresa S M ^a  

^a MAYO CLINIC   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Atrial fibrillation; Epidemiology; Heart failure; Incidence; Prognosis

Indexed keywords

AGED; ARTICLE; COMMUNITY; CONGESTIVE HEART FAILURE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK; UNITED STATES;

AGED; ATRIAL FIBRILLATION; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MINNESOTA; MORTALITY; PROGNOSIS; SEX DISTRIBUTION;

EID: 33645465879     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi694     Document Type: Article

References (29)

1. Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001;37:371-378.
2. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-1369.
3. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J 1996;131:790-795.
4. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-241.
5. Tsang TS, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, Wiebers DO, Sicks JD, Christianson TJ, Seward JB, Gersh BJ. The prevalence of atrial fibrillation in incident stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003;42:93-100.
6. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-484.
7. Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55:358-363.
8. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-521.
9. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:1570-1573.
10. van den Berg MP, van Veldhuisen DJ, Crijns HJ, Lie KI. Reversion of tachycardiomyopathy after beta-blocker. Lancet 1993;341:1667.
11. Cha YM, Redfield MM, Shen WK, Gersh BJ. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation 2004;109:2839-2843.
12. Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardarson T. Chronic atrial fibrillation-epidemiologic features and 14 year follow-up: a case control study. Eur Heart J 1987;8:521-527.
13. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-364.
14. Scheinman MM. Atrial fibrillation and congestive heart failure: the intersection of two common diseases. Circulation 1998;98:941-942.
15. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-2925.
16. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, Diamond PM, Marra MA, Gersh BJ, Wiebers DO, Petty GW, Seward JB. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc 2001;76:467-475.
17. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
18. Melton LJ III. History of the Rochester epidemiology project. Mayo Clin Proc 1996;71:266-274.
19. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-1446.
20. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-674.
21. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.
22. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999;100:87-95.
23. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-1046.
24. Patel PJ, Keating RJ, Gersh BJ, Hodge DO, Hammill SC, Shen WK. Outcome of patients with newly diagnosed atrial fibrillation at the Mayo Clinic and residing in that area. Am J Cardiol 2004;94:1379-1382.
25. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Carlson LA, Seward JB, Tsang TSM. Utilization of non-pharmacological therapy in atrial fibrillation: changing clinical practice over 2 decades. (Abstract). Circulation 2005;112:II574-II575.
26. Miyasaka Y, Barnes ME, Cha SS, Bailey KR, Seward JB, Abhayaratna WP, Gersh BJ, Tsang TSM. Pharmacological therapy following first atrial fibrillation: data from two decades (1980-2000). (Abstract). J Am Coll Cardiol 2005;45:334A.
27. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
28. Miyasaka Y, Barnes ME, Cha SS, Gersh BJ, Seward JB, Abhayaratna WP, Bailey KR, Tsang TSM. Trends in incidence of atrial fibrillation in Olmsted County, Minnesota (1980-2000). (Abstract). J Am Coll Cardiol 2005;45:333A.
29. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-350.